Showing results (1891-1900 of 2,721) with videos related to

Sort By:
Pageof 273
Multiple Sclerosis and Related Disorders|June 10, 2018
Mortality from Listeria monocytogenes meningoencephalitis following escalation to alemtuzumab therapy for relapsing-remitting Multiple SclerosisL J W Canham, A Manara, J Fawcett, et al.
Oncology Nursing Forum|April 24, 1999
A resource kit for women with breast cancer: development and evaluationN Samarel, J Fawcett, L Tulman, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 26, 1999
Variation in diagnostic strategy of the EMG examination--a multicentre studyA Fuglsang-Frederiksen, B Johnsen, M de Carvalho, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Blood pressure changes during short-term fluoxetine treatmentJ D Amsterdam, F Garcia-Espana, J Fawcett, et al.
Nursing Science Quarterly|December 14, 2017
Thoughts About Advancement of the Discipline: Dark Clouds and Bright LightsMarian Turkel, Jacqueline Fawcett, Peggy L Chinn, et al.
Analytical and Bioanalytical Chemistry|June 11, 2019
Ultrahigh-throughput absolute quantitative analysis of linezolid in human plasma by direct analysis in real time mass spectrometry without chromatographic separation and its application to a pharmacokinetic studyLei Yin, Yixuan Feng, Jin Tong, et al.
British Journal of Urology|April 1, 1993
The mobile lithotriptor: an answer for the smaller centreA J Dickinson, D Cranston, A Doble, et al.
The Journal of Biological Chemistry|April 4, 1997
Detection of brain-derived neurotrophic factor in a vesicular fraction of brain synaptosomesJ P Fawcett, R Aloyz, J H McLean, et al.
International Journal of Behavioral Medicine|January 31, 2023
Perceived Executive Functioning Deficits After Diagnosis in Women with Non-Metastatic Breast Cancer Prior to Adjuvant TherapiesSheila N Garland, Joshua Tulk, Nicole Rodriguez, et al.
Journal of Neurosurgery. Spine|September 19, 2012
Optimization of the decision-making process for the selection of therapeutics to undergo clinical testing for spinal cord injury in the North American Clinical Trials NetworkJames Guest, James S Harrop, Bizhan Aarabi, et al.
Pageof 273